Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $213 | $116 | $237 | $708 |
| - Cash | $140 | $93 | $108 | $89 |
| + Debt | $213 | $602 | $599 | $599 |
| Enterprise Value | $285 | $625 | $727 | $1,219 |
| Revenue | $122 | $85 | $41 | $91 |
| % Growth | 43.2% | 107.2% | -54.6% | – |
| Gross Profit | $122 | $85 | $14 | $91 |
| % Margin | 100% | 100% | 33.3% | 100% |
| EBITDA | $77 | $47 | -$10 | $33 |
| % Margin | 63% | 54.7% | -24.5% | 36.9% |
| Net Income | $40 | $24 | -$37 | $2 |
| % Margin | 32.8% | 27.7% | -90.9% | 2.5% |
| EPS Diluted | 0.23 | 0.14 | -0.23 | 0.014 |
| % Growth | 64.3% | 160.9% | -1,731.2% | – |
| Operating Cash Flow | $48 | -$15 | $20 | $15 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | $48 | -$15 | $20 | $15 |